

Ep. 216: “Liver Tissue Development & Engineering” Featuring Dr. David Hay
Apr 19, 2022
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Introduction
00:00 • 2min
Using Chemical Stimulation in Mouse Somatic Cells to Induce Pluri Potent Stem Cells
02:20 • 3min
Is There a Future for Chemical Reprogramming to Generate Pluripotent Cells?
04:51 • 2min
How to Induce Chemical Reprogramming in Human Cells
07:05 • 4min
Sematic Mutation Rates Scale With LifeSpan
10:38 • 3min
The LifeSpan Question Isn't Solved, but Is It?
13:22 • 4min
Is Hemana Poetic Stem Cell Transplantable?
16:58 • 3min
Hemata Poetic Stem Cell Self Signature
20:14 • 3min
Pluri-Po or Matapotic a Precursor?
23:05 • 1min
Is This the Culmination of Our Ability to Examine Hedorigineity Within Populations?
24:22 • 3min
Using Primordial Germ Cell Like Cells From Rat Pluripotent Stem Cells
27:09 • 2min
Are Human Pluripotent Stem Cells Safe?
29:23 • 2min
The Application of Human Stem Cells to Preservation
31:15 • 3min
Hepaticult Organoide Kit - Slash Hepatic Disease
34:05 • 2min
Hippatacite Production From Pluripotent Stem Cells
36:33 • 2min
Using Cell Base Therapies in the Clinical Trials
38:46 • 3min
Transplantation
42:04 • 5min
I Think the Invitro Side Is Really Exciting
47:16 • 4min
The Importance of Machine Learning in a Cell Production System
51:26 • 3min
Stem Cell Therapy
54:13 • 3min
Biotex Start Up Companies - Are You Bringing It to Clinical Trials?
57:27 • 2min
Regenerative Medicine - It's All About Team Building
59:50 • 4min
I Can't Start to Day Without Tea and Coffee
01:03:22 • 3min